Manufacturers/Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc.

28 drugs in NADAC|0 Generic,28 Brand

View Recalls (23)

Total Drugs

28

0G / 28B

Avg Price / Unit

$45.3709

$1.26 – $725.44

Avg 7d Change

+0.04%

Across 11 drugs with changes

7d Activity

6517 flat

of 28 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Drug Portfolio

28 drugs total, 28 shown

Drug Price 7d Change
BETASERON 0.3 MG KIT
interferon beta-1b
$725.4354
per EA
BILTRICIDE 600 MG TABLET
praziquantel
$81.7875
per EA
CLIMARA PRO PATCH
Estradiol and Levonorgestrel
$59.6981
per EA
-0.01%
MENOSTAR 14 MCG/DAY PATCH
estradiol
$38.7928
per EA
-0.13%
KERENDIA 10 MG TABLET
finerenone
$22.8738
per EA
KERENDIA 10 MG TABLET
finerenone
$22.8738
per EA
KERENDIA 10 MG TABLET
finerenone
$22.8738
per EA
KERENDIA 20 MG TABLET
finerenone
$22.8622
per EA
KERENDIA 20 MG TABLET
finerenone
$22.8622
per EA
KERENDIA 20 MG TABLET
finerenone
$22.8622
per EA
KERENDIA 40 MG TABLET
finerenone
$22.8604
per EA
KERENDIA 40 MG TABLET
finerenone
$22.8604
per EA
KERENDIA 40 MG TABLET
finerenone
$22.8604
per EA
CLIMARA 0.0375 MG/DAY PATCH
Estradiol
$18.3130
per EA
+0.04%
CLIMARA 0.1 MG/DAY PATCH
Estradiol
$18.2961
per EA
+0.04%
CLIMARA 0.05 MG/DAY PATCH
Estradiol
$18.2744
per EA
+0.13%
CLIMARA 0.075 MG/DAY PATCH
Estradiol
$18.2725
per EA
CLIMARA 0.06 MG/DAY PATCH
Estradiol
$18.2331
per EA
+0.33%
CLIMARA 0.025 MG/DAY PATCH
Estradiol
$18.2113
per EA
NATAZIA 28 TABLET
estradiol valerate and estradiol valerate/dienogest
$8.4804
per EA
0.00%
BEYAZ 28 TABLET
Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
$8.2907
per EA
+0.03%
SAFYRAL TABLET
Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
$6.8201
per EA
ANGELIQ 0.25 MG-0.5 MG TABLET
drospirenone and estradiol
$6.3770
per EA
ANGELIQ 0.5 MG-1 MG TABLET
drospirenone and estradiol
$6.3502
per EA
-0.14%
YAZ 28 TABLET
Drospirenone and ethinyl estradiol
$5.8495
per EA
-0.02%
YASMIN 28 TABLET
drospirenone and ethinyl estradiol
$4.3997
per EA
-0.03%
CIPRO 10% SUSPENSION
ciprofloxacin
$1.4566
per ML
0.00%
CIPRO 5% SUSPENSION
ciprofloxacin
$1.2572
per ML
+0.15%

FDA Recalls (23)

Recalls matched by company name. Verify current status with FDA.

D-0145-2024
Terminated
Class I

VITRAKVI (larotractenib) oral solution, 20mg/mL, 100 mL bottle, Rx only, Manufactured for Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ 07981. NDC 50419-392-01

Microbial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing

Initiated: 11/6/2023
D-0253-2022
Terminated
Class I

Tinactin (Tolnaftate 1%) POWDER SPRAY NET WT 133g (4.6 oz) can, labeled as (a) Product of Ireland 86940418; (b)Product of Finland 20006106; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, UPC 3 11017 41009 7, NDC 11523-0777-2.

Chemical Contamination: presence of benzene

Initiated: 10/1/2021
D-0251-2022
Terminated
Class I

Tinactin (Tolnaftate 1%) LIQUID SPRAY NET WT150g (5.3 OZ) can, Labeled as (a) Product of Finland 20006101, (b) Product of Ireland 87022897, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, UPC 3 11017 41005 9, NDC 11523-0165-3.

Chemical Contamination: presence of benzene

Initiated: 10/1/2021
D-0242-2022
Terminated
Class II

Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY NET WT 133g (4.6 OZ) can, labeled as (a) UPC 3 11017-410-00 4, NDC 11523-4162-1, Product of Finland 86568411; (b) UPC 3 11017 41000 4, NDC 11523-4162-1, Product of Finland 20006105; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Initiated: 10/1/2021
D-0247-2022
Terminated
Class I

LOTRIMIN AF, (Miconazole nitrate 2%), Jock Itch, Powder Spray, NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-4140-2. UPC 3 11017 41031 8

Chemical Contamination: presence of benzene

Initiated: 10/1/2021
D-0236-2022
Terminated
Class II

LOTRIMIN AF (Miconazole nitrate 2%) Deodorant Powder Spray NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-1272-2 UPC 3 11017 41023 3

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Initiated: 10/1/2021
D-0249-2022
Terminated
Class I

Lotrimin AF (Tolnaftate 1%) Daily Prevention deodorant powder spray, NET WT 160g (5.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, UPC 0 41100 58720 6, NDC 11523-0010-2.

Chemical Contamination: presence of benzene

Initiated: 10/1/2021
D-0239-2022
Terminated
Class II

LOTRIMIN AF (Tolnaftate 1%) DAILY PREVENTION deodorant powder spray NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, UPC 0 41100 59036 7, NDC 11523-0010-1.

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Initiated: 10/1/2021
D-0246-2022
Terminated
Class I

LOTRIMIN AF (Miconazole nitrate 2%) Deodorant Powder Spray, NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-1272-2 UPC 3 11017 41023 3

Chemical Contamination: presence of benzene

Initiated: 10/1/2021
D-0240-2022
Terminated
Class II

LOTRIMIN AF (Tolnaftate 1%) DAILY PREVENTION deodorant powder spray, NET WT 160g (5.6 OZ) can, packaged as (a) single pack, UPC 0 41100 58720 6, NDC 11523-0010-2; (b) 3-pack, UPC 0 41100 58961 3; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland,

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Initiated: 10/1/2021
D-0250-2022
Terminated
Class I

Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, UPC 3 11017 41000 4, NDC 11523-4162-1, Product of Finland 20006105

Chemical Contamination: presence of benzene

Initiated: 10/1/2021
D-0245-2022
Terminated
Class II

Tinactin (Tolnaftate 1%) POWDER SPRAY NET WT 133g (4.6 oz) can, Labeled as (a) Product of Ireland 86940418, (b)Product of Finland 20006106, (c) Product of Ireland with Instant redeemable coupon ( IRC); Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, UPC 3 11017 41009 7, NDC 11523-0777-2.

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Initiated: 10/1/2021
D-0244-2022
Terminated
Class II

Tinactin (Tolnaftate 1%) JOCK ITCH POWDER SPRAY NET WT133g (4.6 oz) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Ireland 86951967, UPC 3 11017 41007 3, NDC 11523-0072-5

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Initiated: 10/1/2021
D-0248-2022
Terminated
Class I

LOTRIMIN AF, (Miconazole nitrate 2%), Powder Spray, NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-0544-2 UPC 3 11017 41025 7

Chemical Contamination: presence of benzene

Initiated: 10/1/2021
D-0237-2022
Terminated
Class II

LOTRIMIN AF (Miconazole nitrate 2%) Jock Itch Powder Spray NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-4140-2. UPC 3 11017 41031 8

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Initiated: 10/1/2021
D-0254-2022
Terminated
Class II

LOTRIMIN AF (Tolnaftate 1%) DAILY PREVENTION deodorant powder spray, NET WT 160g (5.6 OZ) can, UPC 0 41100 58720 6, NDC 11523-0010-2; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland, Packaged with LOTRIMIN ULTRA (butenafine hydrochloride 1%) cream, UPC 0 11017 40823 9, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Japan, ECOM PK UPC 00041100590756 NDC 11523-0010-2

cGMP Deviations: LOTRIMIN AF (Tolnaftate 1%) manufactured at the same facility where other lots were found to be contaminated with benzene.

Initiated: 10/1/2021
D-0243-2022
Terminated
Class II

Tinactin (Tolnaftate 1%) LIQUID SPRAY NET WT150g (5.3 OZ) can, labeled as (a) Product of Finland 20006101, (b) Product of Ireland 87022897, (c) Product of Ireland 87022897, with an instant redeemable coupon (IRC) tag attached to the can; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, UPC 3 11017 41005 9, NDC 11523-0165-3 Tinactin (Tolnaftate 1%) LIQUID SPRAY NET WT150g (5.3 OZ) can, Labeled as (a) Product of Finland 20006101, (b) Product of Ireland 87022897, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, UPC 3 11017 41005 9, NDC 11523-0165-3.

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Initiated: 10/1/2021
D-0252-2022
Terminated
Class I

Tinactin (Tolnaftate 1%) JOCK ITCH POWDER SPRAY NET WT133g (4.6 oz) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Finland 20066104 UPC 3 11017 41007 3, NDC 11523-0072-5

Chemical Contamination: presence of benzene

Initiated: 10/1/2021
D-0238-2022
Terminated
Class II

LOTRIMIN AF (Miconazole nitrate 2%) Powder Spray NET WT 133g (4.6 OZ) can, packaged as (a) a single pack NDC 11523-0544-2 UPC 3 11017 41025 7; (b) 3 pack, NDC 11523-0544-2, UPC 0 41100 58594 3; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, ,

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Initiated: 10/1/2021
D-0241-2022
Terminated
Class II

Lotrimin AF (Miconazole nitrate 2%) Liquid Spray NET WT 133g (4.6 oz) can, Packaged as (a) single pack, UPC 0 41100 40788 7, NDC 11523-4327-1; (b) 3-pack UPC 0 41100 58593 6; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Initiated: 10/1/2021
D-807-2013
Terminated
Class III

Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin

Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.

Initiated: 6/13/2013
D-156-2013
Terminated
Class III

Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2

Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.

Initiated: 5/31/2012
D-1433-2012
Terminated
Class II

Estradiol Hemihydrate M20 EP/USP Powder, packaged in a) 1.5 kg and b) 2.5 kg fiber drums, Rx only, Art. No. 165811, Bayer Pharma AG, D-13342 Berlin.

Cross Contamination w/Other Products: This active pharmaceutical ingredient is being recalled due to cross contamination with another product.

Initiated: 5/8/2012